Karen H. Vousden, PhD - Bristol Myers Squibb
Karen H. Vousden, PhD
Principal Group Leader of The Francis Crick Institute and Former Chief Scientist of Cancer Research UK
Dr. Vousden, age 65, has been a senior group leader at The Francis Crick Institute in London since February 2017 and served as the chief scientist of Cancer Research UK (CRUK) between 2016-2022.
Dr. Vousden brings to the Board more than 30 years of experience leading groundbreaking cancer research. She is a fellow of the Royal Society and a foreign associate of the National Academy of Sciences. She serves as a member of the Science Advisory Boards of Kovina Therapeutics, the University Cancer Center Frankfurt, Ludwig Institute for Cancer Research, PMV Pharma, Raze Therapeutics, Swiss Institute for Experimental Cancer Research, and Volastra Therapeutics. Dr. Vousden serves as president of the British Association of Cancer Research.
She is founder and consultant of Faeth Therapeutics, Inc., a fellow of the Royal Society and a foreign associate of the National Academy of Sciences.